Article Information
History
- May 1, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- aNeurology and Psychiatry Department. Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”. Mexico City, Mexico
- ↵*Corresponding authors:
Dr. Erwin Chiquete. Departamento de Neurología y Psiquiatría. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Avenida Vasco de Quiroga No. 15, Colonia Belisario Domínguez Sección XVI, Delegación Tlalpan C.P.14080. Ciudad de México. México. E-mail: erwinchiquete{at}hotmail.com. Tel: +52 5424 7200 ext. 4177.
Posted May 01, 2020.
Methods of An Open-Label Proof-Of-Concept Trial of Intravenous Valproic Acid for Severe COVID-19
